Related Experiment Video
Updated: May 1, 2026
05:08
Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
10.8K
Pharmacogenetics of heart failure
Luisa Mestroni1, Rene L Begay, Sharon L Graw
1University of Colorado Cardiovascular Institute and Adult Medical Genetics Program, Aurora, Colorado, USA.
Current Opinion in Cardiology
|April 11, 2014
Summary
Personalized medicine uses genetic information to tailor cardiovascular disease treatments. Pharmacogenetics, analyzing individual genetic data, offers improved patient management and optimized drug therapies.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pharmacology
Background:
- Personalized medicine aims to individualize patient care using genetic insights.
- Cardiovascular disease management can benefit from genetic information for diagnosis, prevention, and therapy.
Purpose of the Study:
- To review the applications of personalized medicine in cardiovascular disease.
- To explore the role of genetic information in optimizing cardiovascular treatments.
Main Methods:
- Review of current evidence on genetic variants influencing cardiovascular drug response.
- Analysis of studies linking genetic profiles to treatment outcomes in heart failure, arrhythmias, dyslipidemia, and hypertension.
Main Results:
- Common polymorphic variants in modifier genes impact drug response across various cardiovascular conditions.
- Specific genetic variants (e.g., adrenergic receptors) are associated with varied responses to heart failure therapies.
- Leveraging genetic data for personalized cardiovascular therapy remains a key challenge.
Conclusions:
- Technological advancements are moving personalized medicine from research to clinical practice.
- Healthcare providers must adapt diagnostic approaches for personalized medicine.
- Pharmacogenetics provides a framework for enhancing patient management through genetic data.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:29Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
01:27Principles of Pharmacogenetics: Types of Genetic Variants
138
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:27Pharmacogenetics of Drug Metabolism: Overview
194
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81